Please assess the completion status of the following clinical trial:

Trial Title: Intranasal Fentanyl for Initial Treatment of a Vaso-occlusive Crisis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Sickle Cell Disease~* Ages 3 years - 21 years~Exclusion Criteria for Enrollment:~* Pregnancy~* Known allergy to Fentanyl~* Usage of daily home opiates~Exclusion Criteria at presentation in ED with a painful crisis:~* Wong Baker FACES Pain Score \<6~* Systolic blood pressure \< 5 percentile for age~* Oxygen saturation \<92% on room air~* Temperature \> 102°F~* Respiratory distress~* Priapism~* Isolated abdominal pain~* Isolated headache~* New neurological symptoms~* Severe rhinorrhea or epistaxis~* History of trauma~* Pregnancy

- Gender: ALL
- Minimum Age: 3 Years
- Maximum Age: 21 Years
- Healthy Volunteers: f

Study Arms:
- Intranasal Saline (Type: PLACEBO_COMPARATOR): None
- Intranasal Fentnayl (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).